In symptomatic primary hyperparathyroid patients, significantly higher plasma levels of tissue plasminogen activator and lower platelet activator inhibitor-1 (PAI-1) and tissue factor pathway inhibitor F levels compared to controls matched for age, sex, and body mass index were reported. Here, PLAT is linked to primary hyperparathyroidism.